A Liberian doctor treated with experimental American anti-Ebola serum ZMapp has died, the west African nation said on Monday.
The Americans were infected in Liberia along with a Spanish priest who died on 12 August, despite also receiving ZMapp.
The very small available stocks of ZMapp, which has never been through clinical trials on humans, have now been used up, according to the lab that produces it.
The WHO has been discussing the use of unapproved drugs as a way of getting a handle on an outbreak in Africa that has already cost more than 1 400 lives.
There is currently no available cure or vaccine for Ebola, but several drugs are under development.
Tokyo said on Monday it was ready to offer an experimental drug developed by a Japanese company to help stem the global tide of Ebola.
Avigan, which is taken in tablet form, was approved as an anti-influenza drug in Japan in March and is currently in clinical tests in the United States.
A panel of medical experts convened by the WHO earlier this month determined it was “ethical” to provide experimental treatments, given the scale of the epidemic.
Like us on Facebook or follow us on Twitter to get the latest news about Vietnam!
Đăng ký: VietNam News